相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer with Acquired Endocrine Resistance
Alexandra F. Leary et al.
CLINICAL CANCER RESEARCH (2010)
The Mammalian Anti-Proliferative BTG/Tob Protein Family
G. Sebastiaan Winkler
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Molecular predictors of response to trastuzumab and lapatinib in breast cancer
Francisco J. Esteva et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis
Tetsu Hayashida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
ERBB1 and ERBB2 Have Distinct Functions in Tumor Cell Invasion and Intravasation
Dmitriy Kedrin et al.
CLINICAL CANCER RESEARCH (2009)
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast Cancer
Stephen Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
BTG/TOB factors impact deadenylases
Fabienne Mauxion et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Sherene Loi et al.
BMC GENOMICS (2008)
A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling
P. K. Julka et al.
BRITISH JOURNAL OF CANCER (2008)
Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells
G. E. Konecny et al.
BRITISH JOURNAL OF CANCER (2008)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
Michele Sabbah et al.
DRUG RESISTANCE UPDATES (2008)
The BTG2 protein is a general activator of mRNA deadenylation
Fabienne Mauxion et al.
EMBO JOURNAL (2008)
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy
Stephen Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer
Henry L. Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain
Brunilde Gril et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Tumor Progression and Oncogene Addiction in a PDGF-B-Induced Model of Gliomagenesis
Filippo Calzolari et al.
NEOPLASIA (2008)
A stromal gene signature associated with inflammatory breast cancer
Brenda J. Boersma et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression
Hui-Wen Lo et al.
CANCER RESEARCH (2007)
Targeting HER proteins in cancer therapy and the role of the non-target HER3
A. C. Hsieh et al.
BRITISH JOURNAL OF CANCER (2007)
Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3
Stefano Farioli-Vecchioli et al.
FASEB JOURNAL (2007)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
Lao H. Saal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E. Geyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein
Hirofumi Kawakubo et al.
CANCER RESEARCH (2006)
A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor - Positive tumors
Kun Yu et al.
CLINICAL CANCER RESEARCH (2006)
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen
J Moffat et al.
CELL (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
ErbB3-dependent motility and intravasation in breast cancer metastasis
CS Xue et al.
CANCER RESEARCH (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation
AD Boiko et al.
GENES & DEVELOPMENT (2006)
Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylation
S Hiscox et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death
JW Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549
G Sithanandam et al.
ONCOGENE (2005)
Gene-expression pro-files to predict distant metastasis of lymph-node-negative primary breast cancer
YX Wang et al.
LANCET (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma
K Struckmann et al.
CANCER RESEARCH (2004)
B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/Smad signaling
S Park et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
HJ Zhao et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
Expression of the NF-κB-responsive gene BTG2 is aberrantly regulated in breast cancer
H Kawakubo et al.
ONCOGENE (2004)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
Gene expression predictors of breast cancer outcomes
E Huang et al.
LANCET (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Expression of B-cell translocation gene 2 protein in normal human tissues
J Melamed et al.
TISSUE & CELL (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
The ErbB receptor tyrosine family as signal integrators
NE Hynes et al.
ENDOCRINE-RELATED CANCER (2001)
Antiproliferative B cell translocation gene 2 protein is downregulated post-transcriptionally as an early event in prostate carcinogenesis
MA Ficazzola et al.
CARCINOGENESIS (2001)
Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism
TU Ha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation
D Prévot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription
D Guardavaccaro et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
